Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Sun Min Lim*, Chung Mo Nam†, Youn Nam Kim†, Sin Ae Lee‡, Eun Hye Kim*, Sung Pil Hong*,§, Tae Il Kim*,§, Won Ho Kim*,§,∥, and Jae Hee Cheon*,§,∥*
*Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
†Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea.
‡Department of Nursing, Yonsei University College of Nursing, Seoul, Korea.
§Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
∥Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Correspondence to: Jae Hee Cheon. Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea. Tel: +82-2-2228-1990, Fax: +82-2-393-6884, geniushee@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2013;7(1):51-57. https://doi.org/10.5009/gnl.2013.7.1.51
Published online January 11, 2013, Published date January 31, 2013
Copyright © Gut and Liver.
The symptoms of inflammatory bowel disease (IBD) fluctuate considerably over time. However, it has not been determined whether these symptoms are affected by the menstrual cycle in female IBD patients. This study analyzed the effects of the menstrual cycle on IBD symptom variation.
This was a prospective study of 91 study subjects (47 IBD patients and 44 healthy controls) who reported daily symptoms and signs throughout their menstrual cycles.
IBD patients had significantly more frequent gastrointestinal symptoms, such as nausea (30% vs 7%, p=0.006), flatulence (53% vs 22%, p=0.003), and abdominal pain as compared to controls (68% vs 38%, p=0.006). The IBD patients also experienced more frequent systemic premenstrual symptoms than the controls (79% vs 50%, p=0.003). More severe abdominal pain (p=0.002) and lower mean general condition scores (p=0.001) were noted during the menstrual phase as compared to the pre- or post-menstrual phase in both groups. IBD patients experienced more frequent premenstrual gastrointestinal symptoms than controls, but their IBD symptoms did not change significantly during the menstrual cycle.
Knowledge of the cyclic alterations in gastrointestinal and systemic symptoms may be helpful in determining the true exacerbation of disease in female IBD patients.
Keywords: Inflammatory bowel diseases, Menstrual cycle, Women
Gut Liver 2013; 7(1): 51-57
Published online January 31, 2013 https://doi.org/10.5009/gnl.2013.7.1.51
Copyright © Gut and Liver.
Sun Min Lim*, Chung Mo Nam†, Youn Nam Kim†, Sin Ae Lee‡, Eun Hye Kim*, Sung Pil Hong*,§, Tae Il Kim*,§, Won Ho Kim*,§,∥, and Jae Hee Cheon*,§,∥*
*Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
†Department of Biostatistics, Yonsei University College of Medicine, Seoul, Korea.
‡Department of Nursing, Yonsei University College of Nursing, Seoul, Korea.
§Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
∥Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Correspondence to: Jae Hee Cheon. Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea. Tel: +82-2-2228-1990, Fax: +82-2-393-6884, geniushee@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The symptoms of inflammatory bowel disease (IBD) fluctuate considerably over time. However, it has not been determined whether these symptoms are affected by the menstrual cycle in female IBD patients. This study analyzed the effects of the menstrual cycle on IBD symptom variation.
This was a prospective study of 91 study subjects (47 IBD patients and 44 healthy controls) who reported daily symptoms and signs throughout their menstrual cycles.
IBD patients had significantly more frequent gastrointestinal symptoms, such as nausea (30% vs 7%, p=0.006), flatulence (53% vs 22%, p=0.003), and abdominal pain as compared to controls (68% vs 38%, p=0.006). The IBD patients also experienced more frequent systemic premenstrual symptoms than the controls (79% vs 50%, p=0.003). More severe abdominal pain (p=0.002) and lower mean general condition scores (p=0.001) were noted during the menstrual phase as compared to the pre- or post-menstrual phase in both groups. IBD patients experienced more frequent premenstrual gastrointestinal symptoms than controls, but their IBD symptoms did not change significantly during the menstrual cycle.
Knowledge of the cyclic alterations in gastrointestinal and systemic symptoms may be helpful in determining the true exacerbation of disease in female IBD patients.
Keywords: Inflammatory bowel diseases, Menstrual cycle, Women
Table 1 Baseline Characteristics of Women with Inflammatory Bowel Disease and Controls
Data are presented as mean±SD or number (%).
Table 2 Comparison of Symptoms between Women with Inflammatory Bowel Disease and Controls
Data are presented as number (%).
Table 3 Mean Gastrointestinal Symptom Severity during Phases of the Menstrual Cycle in Inflammatory Bowel Disease Patients and Healthy Controls
Data are presented as mean±SD.
Table 4 Mean Specific Inflammatory Bowel Disease (IBD)-Related Symptom Frequency of IBD Patients According to Phases of the Menstrual Cycle
Data are presented as number (%).